The CDC has issued interim effectiveness estimates for the 2024-2025 seasonal influenza and 2024-2025 COVID-19 vaccines.
Despite variations by age group and influenza virus type, the 2023-2024 influenza vaccine was protective against outpatient illness in pediatric and adult patients.
WHO has published updated guidance on the implementation of an integrated surveillance system for influenza and other ...
The recommendations were made following a meeting that included experts from the FDA, the Centers for Disease Control and Prevention, and the Department of Defense.
Even as more people are dying from flu, the Trump administration has postponed vaccine planning for next fall's flu season.
and public health experts in the United States believe that available treatments and vaccines, as ... Dec. 13, 2024 — Influenza or flu virus remains infectious in refrigerated raw milk for up to ...
The United Kingdom’s Health Security Agency (HSA) yesterday published it first annual report on infectious disease trends, ...
Previous exposures to older flu strains prime the immune system to produce antibodies against bird flu (H5N1).
2d
GlobalData on MSNGSK and UK researchers plan to study Shingrix and dementia risk reduction linkThe study will analyse electronic health records of 65- and 66-year olds from the UK’s National Health Service (NHS).
Based on the data presented, the committee agreed that there was a need to change the influenza A/H3N2 virus strains from the 2024-2025 formula. Recommendations on the strain composition of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results